In The News :: Aerami Therapeutics Holdings, Inc.

Sep 19, 2023

Tribute to Lisa Yañez

Mar 11, 2023

Aerami Therapeutics – Developing Treatment for Serious Cardiopulmonary Conditions

Feb 24, 2023

JP Morgan 2023 – Lisa Yañez (PharmaPhorum)

Feb 23, 2023

Developing Precision Inhaled Therapy to Treat Pulmonary Arterial Hypertension with Lisa Yanez Aerami Therapeutics (Empowered Patient Podcast with Karen Jagoda)

Jan 6, 2023

Chutes & Ladders— Aerami Therapeutics welcomed Lisa Yañez as its new CEO (Fierce Biotech)

Dec 23, 2022

Dosing Complete in Phase 1 Trial of AER-901, Inhaled Imatinib (Pulmonary Hypertension News)

Dec 21, 2022

Durham drugmaker names new CEO at pivotal juncture (Triangle Business Journal, Subscription Required)

Dec 21, 2022

Durham biotech startup Aerami names industry veteran as new CEO (WRAL TechWire)

Dec 21, 2022

Appointments and advancements (BioWorld, Subscription Required)

Dec 21, 2022

Greene becomes chief investment officer at Hevolution, and updates from Aerami and Curate (BioCentury, Subscription Required)